What are the real risks for breast cancer?

References

• Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. Cancer J Clin 2010;60:277–300
   PubMed Web of Science ®Google Scholar
• http://www.seer.cancer.gov/statfacts/html/breast.html
   Google Scholar
• Assessing the odds. Lancet 1997;350:1563
   PubMed Web of Science ®Google Scholar
• Patnaik JL, Byers T, Diguiseppi C, . Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: A retrospective cohort study. Breast Cancer Res 2011;13:R64
   PubMed Web of Science ®Google Scholar
• Phillips KA, Glendon G, Knight JA. Putting the risk of breast cancer in perspective. N Engl J Med 1999;340:141–4
   PubMed Web of Science ®Google Scholar
• http://www.seer.cancer.gov/csr/1975_2007/browse_csr.php?section=4 &page=sect_04_table.12.html
   Google Scholar
• US Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: Recommendation statement. Ann Intern Med 2005;143: 355–61
   PubMed Web of Science ®Google Scholar
• Wong MW, Nordfors C, Mossman D, . BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer. Breast Cancer Res Treat 2011;127:853–9
   PubMed Web of Science ®Google Scholar
• Reyna VF, Nelson WL, Dieckmann NF. How numeracy influences risk comprehension and medical decision making. Psychol Bull 2009;135:943–73
   PubMed Web of Science ®Google Scholar
• Gigerenzer G, Gaissmaier W, Kurz-Milcke E, . Helping doctors and patients make sense of health statistics. Psychol Sci Public Interest 2008;8:53–96
   Google Scholar
• Asilomar Working Group on Recommendations for Reporting of Clinical Trials in the Biomedical Literature. Checklist of information for inclusion in reports of clinical trials. Ann Intern Med 1996;124:741–3
   PubMed Web of Science ®Google Scholar
• Altman DG, Schulz KF, Moher D, . The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001;134:663–94
   PubMed Web of Science ®Google Scholar
• Moher D, Schultz KF, Altman D for the CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001;285:1987–91
   PubMed Web of Science ®Google Scholar
• Fisher B, Costantino JP, Wickerham DL, and other NSABP Investigators. Tamoxifen for the prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998;90:1371–88
   PubMed Web of Science ®Google Scholar
• Bluming A. A drug that needs further testing. LA Times Nov 4, 1998
   Google Scholar
• Goodman SN. Toward evidence-based medical statistics. 1. The P value fallacy. Ann Intern Med 1999;130:995–1004
   PubMed Web of Science ®Google Scholar
• Edwards A, Elwyn G, Mulley A. Explaining risks: turning numerical data into meaningful pictures. BMJ 2002;324:827–30
   PubMed Web of Science ®Google Scholar
• Paling J. Strategies to help patients understand risks. BMJ 2003; 327:745–8
   PubMed Web of Science ®Google Scholar
• Kavvoura FK, Liberopoulos G, Ioannidis JPA. Selection in reported epidemiological risks: An empirical assessment. PLoS Med 2007;4:456–65
   Web of Science ®Google Scholar
• Baglioni P. Screening and breast cancer (letter). N Engl J Med 2006;354:768
   Google Scholar
• Elmore JG, Gigerenzer G. Benign breast disease – the risks of communicating risk. N Engl J Med 2005;353:297–9
   PubMed Web of Science ®Google Scholar
• Kane RC. The clinical significance of statistical significance. Oncologist 2008;13:1129–33
   PubMed Web of Science ®Google Scholar
• Braitman LE. Confidence intervals assess both clinical significance and statistical significance. Ann Intern Med 1991;114: 515–17
   PubMed Web of Science ®Google Scholar
• Altman DG. Confidence intervals in research evaluation. ACP J Club 1992;A-28–9
   Google Scholar
• Taubes G. Epidemiology faces its limits. The search for subtle links between diet, lifestyle, or environmental factors and disease is an unending source of fear, but often yields little certainty. Science 1995;269:164–9
   PubMed Web of Science ®Google Scholar
• Smith GD, Ebrahim S. Data dredging, bias or confounding. They can all get you into the BMJ and the Friday papers. BMJ 2002;325:1437–8
   PubMed Web of Science ®Google Scholar
• Zhang CX, Ho SC, Cheng SZ, . Effect of dietary fiber intake on breast cancer risk according to estrogen and progesterone receptor status. Eur J Clin Nutr 2011;20:199–206
   Google Scholar
• Verla-Tebit E, Chang-Claude J. Anthropomorphic factors and the risk of premenopausal breast cancer in Germany. Eur J Cancer Prev 2005;14:419–26
   PubMed Web of Science ®Google Scholar
• Berstad P, Coates RJ, Bernstein L, . A case-control study of body mass index and breast cancer risk in white and African-American women. Cancer Epidemiol Biomarkers Prev 2010;19: 1532–44
   PubMed Web of Science ®Google Scholar
• Challier B, Perarnau J-M, Viel J-F. Garlic, onion and cereal fibre as protective factors for breast cancer: A French case-control study. Eur J Epidemiol 1998;14:737–47
   PubMed Web of Science ®Google Scholar
• Nielsen NR, Zhang ZF, Kristensen TS, . Self reported stress and risk of breast cancer: prospective cohort study. BMJ 2005; 331:548–52
   PubMed Web of Science ®Google Scholar
• Kim EH, Hankinson SE, Eliassen AH, Willett WC. A prospective study of grapefruit and grapefruit juice intake and breast cancer risk. Br J Cancer 2008;98:240–1
   PubMed Web of Science ®Google Scholar
• Brasky TM, Lampe JW, Potter JD, . Specialty supplements and breast cancer risk in the Vitamins and Lifestyle (VITAL) cohort. Cancer Epidemiol Biomarkers Prev 2010;19: 1696–708
   PubMed Web of Science ®Google Scholar
• The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701–12
   PubMed Web of Science ®Google Scholar
• Bardia A, Olson JE, Vachon CM, . Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study. Breast Cancer Res Treat 2011;126:149–55
   PubMed Web of Science ®Google Scholar
• Li J, Seibold P, Chang-Claude J, . Coffee consumption modifies risk of estrogen receptor negative breast cancer. Breast Cancer Res 2011;13:R49
   PubMed Web of Science ®Google Scholar
• Bardia A, Vachon CM, Olson JE, . Relative weight at age 12 and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2008;17:374–8
   PubMed Web of Science ®Google Scholar
• Borugian MJ, Spinelli JJ, Abanto Z, . Breast cancer incidence and neighborhood income. Health Rep 2011;22:7–13
   PubMedGoogle Scholar
• Xue F, Willett WC, Rosner BA, . for the Nurses’ Health Study. Cigarette smoking and the incidence of breast cancer. Arch Intern Med 2011;171:125–33
   PubMed Web of Science ®Google Scholar
• Ahlgren M, Sorensen T, Wohlfahrt J, . Birth weight and risk of breast cancer in a cohort of 106,504 women. Int J Cancer 2003;107:997–1000
   PubMed Web of Science ®Google Scholar
• Stripp C, Overvad K, Christensen J, . Fish intake is positively associated with breast cancer incidence rate. J Nutr 2003;133: 3664–9
   PubMed Web of Science ®Google Scholar
• dos Santos Silva I, De Stavola B, McCormack V, Collaborative Group of Pre-Natal Risk Factors and Subsequent risk of Breast Cancer. Birth size and breast cancer risk: Re-analysis of individual participant data from 32 studies. PLoS Med 2008;5:1372–86
   Web of Science ®Google Scholar
• Largent JA, Bernstein L, Horn-Ross PL, . Hypertension, antihypertensive medication use, and breast cancer risk in the California Teachers Study Cohort. Cancer Causes Control 2010;21: 1615–24
   PubMed Web of Science ®Google Scholar
• Kloog I, Portnov BA, Rennert HS, Haim A. Does the modern urbanized sleeping habitat pose a breast cancer risk? Chronobiol Int 2011;28:76–80
   PubMed Web of Science ®Google Scholar
• Kabat GC, Kim M, Phipps AI, . Smoking and alcohol consumption in relation to risk of triple-negative breast cancer in a cohort of postmenopausal women. Cancer Causes Control 2011; 22:775–83
   PubMed Web of Science ®Google Scholar
• Chlebowski RT, Hendrix SL, Langer RD, ., for the WHI Investigators. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health initiative randomized trial. JAMA 2003;289: 3243–53
   PubMed Web of Science ®Google Scholar
• Rossouw JE, Anderson GL, Prentice RL, . Writing Group for the Women's Health Initiative investigators. Risks and benefits of estrogen plus progestin in healthy post menopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321–33
   PubMed Web of Science ®Google Scholar
• Michels KB, Rosner BA, Chumlea WC, . Preschool diet and adult risk of breast cancer. Int J Cancer 2006;118:749–54
   PubMed Web of Science ®Google Scholar
• Wise LA, Palmer JY, Boggs DA, . Abuse victimization and risks of breast cancer in the Black Women's Health Study: Abuse and breast cancer risk in black women. Cancer Causes Control 2011;22:659–69
   PubMed Web of Science ®Google Scholar
• Monroe KR, Murphy SP, Kolonel LN, . Prospective study of grapefruit intake and risk of breast cancer in postmenopausal women: the Multiethnic Cohort Study. Br J Cancer 2007;97: 440–5
   PubMed Web of Science ®Google Scholar
• Biggar RJ, Wohlfahert J, Oudi A, . Digoxin use and the risk of breast cancer. J Clin Oncol 2011;29:2165–70
   PubMed Web of Science ®Google Scholar
• Megdal SP, Kroenke CH, Laden F, . Night work and breast cancer risk: a systemic review and meta-analysis. Eur J Cancer 2005;41:2023–32
   PubMed Web of Science ®Google Scholar
• Schernhammer ES, Laden F, Speizer FE, . Rotating night shifts and risk of breast cancer in women participating in the Nurses’ Health Study. J Natl Cancer Inst 2001;93:1563–8
   PubMed Web of Science ®Google Scholar
• Kinnunen TI, Riitta L, Gissler M, . Pregnancy weight gain and breast cancer risk. BMC Womens Health 2004;4:7
   PubMedGoogle Scholar
• Cerne JZ, Ferk P, Leskosek B, Gersak K. Hormone replacement therapy and some risk factors for breast cancer among Slovenian postmenopausal women. Climacteric 2011;14:458–63
   PubMed Web of Science ®Google Scholar
• Pukkala F, Auvinen A, Wahlberg G. Incidence of cancer among Finnish airline cabin attendants, 1967–1992. BMJ 1995;311: 649–52
   PubMed Web of Science ®Google Scholar
• Mawson AR. Breast cancer in female flight attendants. Lancet 1998;352:626
   PubMed Web of Science ®Google Scholar
• Choi JY, Lee KM, Park SK, . Association of paternal age at birth and the risk of breast cancer in offspring: a case control study. BMC Cancer 2005;5:143
   PubMedGoogle Scholar
• Elias SG, Peeters PH, Grobbee DE, van Noord PA. Breast cancer risk after caloric restriction during the 1944–1945 Dutch famine. J Natl Cancer Inst 2004;96:539–46
   PubMed Web of Science ®Google Scholar
• Cnattingius S, Torrang A, Ekbom A, . Pregnancy characteristics and maternal risk of breast cancer. JAMA 2005;294: 2474–80
   PubMed Web of Science ®Google Scholar
• Velicer CM, Heckbert SR, Lampe JW, . Antibiotic use in relation to the risk of breast cancer. JAMA 2004;291:827–35
   PubMed Web of Science ®Google Scholar
• Romleu I, Lazcano-Ponce E, Sanchez-Zamorano LM, . Carbohydrates and the risk of breast cancer among Mexican women. Cancer Epidemiol Biomarkers Prev 2004;13:1283–9
   PubMed Web of Science ®Google Scholar
• Ramadhani MK, Elias SG, van Noord PAH, . Innate left handedness and risk of breast cancer: case-cohort study. Br Med J 2005;331:882–3
   PubMed Web of Science ®Google Scholar
• Barker DJP, Osmond C, Thornburg KL, . A possible link between the pubertal growth of girls and breast cancer in their daughters. Am J Human Biol 2008;20:127–31
   PubMed Web of Science ®Google Scholar
• Rafnsson V, Tulinius H, Jónasson JG, Hrafnkelsson J. Risk of breast cancer in female flight attendants: a population-based study (Iceland). Cancer Causes Control 2001;12:95–101
   PubMed Web of Science ®Google Scholar
• Kaushal M, Mishra AK, Raju BS, . Betel quid chewing as an environmental risk factor for breast cancer. Mutat Res 2010; 703:143–8
   PubMed Web of Science ®Google Scholar
• Kangmin Z, Hunter S, Payne-Wiks K, . Use of electric bedding devices and risk of breast cancer in African-American women. Am J Epidemiol 2003;158:798–806
   PubMed Web of Science ®Google Scholar
• Lowe LG, Guy M, Mansi JL, . Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur J Cancer 2005;41: 1164–9
   PubMed Web of Science ®Google Scholar
• Crew KD, Gammon MD, Steck SE, . Association between plasma 25-hydroxyvitamin D and breast cancer risk. Cancer Prev Res 2009;2:598–604
   PubMed Web of Science ®Google Scholar
• Sasco AJ, Merrill RM, Dari I, . A case-control study of lung cancer in Casablanca, Morocco. Cancer Causes Control 2002; 13:609–16
   PubMed Web of Science ®Google Scholar
• Enger S, Ross RK, Paganini-Hill A, . Alcohol consumption and breast cancer oestrogen and progesterone receptor status. Br J Cancer 1999;79:1308–14
   PubMed Web of Science ®Google Scholar
• Nasca PC, Liu S, Baptiste MS, . Alcohol consumption and breast cancer: estrogen receptor status and histology. Am J Epidemiol 1994;140:980–8
   PubMed Web of Science ®Google Scholar
• Li CI, Malone KE, Porter PL, . The relationship between alcohol use and risk of breast cancer by histology and hormone receptor status among women 65–79 years of agelabel. Cancer Epidemiol Biomarkers Prev 2003;12:1061–6
   PubMed Web of Science ®Google Scholar
• Suzuki R, Ye W, Rylander-Rudqvist T, . Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: A prospective cohort study. J Natl Cancer Inst 2005;97:1601–8
   PubMed Web of Science ®Google Scholar
• Chen WY, Rosner B, Hankinson SE, . Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA 2011;306:1884–90
   PubMed Web of Science ®Google Scholar
• Cooper JA, Rohan TE, Cant EL, . Risk factors for breast cancer by oestrogen receptor status: a population-based case-control study. Br J Cancer 1989;59:119–25
   PubMed Web of Science ®Google Scholar
• Yoo KY, Tajima K, Miura S, . Breast cancer risk factors according to combined estrogen and progesterone receptor status: a case-control analysis. Am J Epidemiol 1997;146: 307–14
   PubMed Web of Science ®Google Scholar
• Huang WY, Newman B, Millikan RC, . Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol 2000;151: 703–14
   PubMed Web of Science ®Google Scholar
• Cotterchio M, Krieger N, Theis B, . Hormonal factors and the risk of breast cancer according to estrogen-and progesterone-receptor Subgroup. Cancer Epidemiol Biomarkers Prev 2003; 12:1053–60
   PubMed Web of Science ®Google Scholar
• Potter JD, Cerhan JR, Sellers TA, . Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there? Cancer Epidemiol Biomarkers Prev 1995;4:319–26
   PubMed Web of Science ®Google Scholar
• Bluming AZ, Tavris C. Hormone replacement therapy: real concerns and false alarms. Cancer J 2009;15:93–104
   PubMed Web of Science ®Google Scholar
• Ragaz J. Presented at the 33rd Annual San Antonio Breast Cancer Symposium; Dec 8–12, 2010, San Antonio. Abstr #1410
   Google Scholar
• Young NS, Ioannidis JAP, Al-Ubaydi O. Why current publication practices may distort science. PLoS Med 2008;5:1418–22
   Web of Science ®Google Scholar
• Dentzer S. Communicating medical news – pitfalls of health care journalism. N Engl J Med 2009;360:1–3
   PubMed Web of Science ®Google Scholar
• Fleming TR. Clinical trials: Discerning hype from substance. Ann Intern Med 2010;153:400–6
   PubMed Web of Science ®Google Scholar
• L'Estrange R. Fables of Aesop and other eminent mythologists: with morals and reflections. 1692
   Google Scholar